Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alignment Healthcare (ALHC) Return on Sales (2020 - 2025)

Historic Return on Sales for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to 0.0%.

  • Alignment Healthcare's Return on Sales rose 400.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.05% for FY2024, which is 300.0% up from last year.
  • As of Q3 2025, Alignment Healthcare's Return on Sales stood at 0.0%, which was up 400.0% from 0.02% recorded in Q2 2025.
  • In the past 5 years, Alignment Healthcare's Return on Sales registered a high of 0.02% during Q2 2025, and its lowest value of 0.21% during Q1 2021.
  • Over the past 5 years, Alignment Healthcare's median Return on Sales value was 0.08% (recorded in 2023), while the average stood at 0.08%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -2000bps in 2021, then surged by 1100bps in 2022.
  • Quarter analysis of 5 years shows Alignment Healthcare's Return on Sales stood at 0.16% in 2021, then grew by 2bps to 0.16% in 2022, then skyrocketed by 36bps to 0.1% in 2023, then surged by 56bps to 0.04% in 2024, then surged by 108bps to 0.0% in 2025.
  • Its Return on Sales stands at 0.0% for Q3 2025, versus 0.02% for Q2 2025 and 0.01% for Q1 2025.